• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932

Professional Introduction to 3-Bromo-5-(chloromethyl)-4-methylpyridine (CAS No. 1805480-93-6)

3-Bromo-5-(chloromethyl)-4-methylpyridine, with the chemical formula C?H?BrClN?, is a significant compound in the field of pharmaceutical and agrochemical research. This compound belongs to the pyridine class of heterocyclic aromatic compounds, which are widely recognized for their diverse biological activities and industrial applications. The presence of both bromo and chloromethyl substituents on the pyridine ring makes it a versatile intermediate for synthesizing various pharmacologically active molecules.

The CAS number 1805480-93-6 uniquely identifies this compound and ensures consistency in its nomenclature across scientific literature and databases. This compound has garnered attention due to its potential role in the development of novel therapeutic agents. Pyridine derivatives are well-documented for their involvement in drug discovery, particularly in the synthesis of kinase inhibitors, antiviral agents, and antimicrobial compounds.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting various disease pathways. Among these, protein kinases have been extensively studied due to their critical roles in cellular signaling. The bromo and chloromethyl functional groups in 3-Bromo-5-(chloromethyl)-4-methylpyridine provide reactive sites that can be exploited for covalent bond formation with target proteins. This property makes it an attractive building block for designing kinase inhibitors.

One of the most compelling applications of this compound is in the development of targeted cancer therapies. Kinase overexpression or mutations are frequently observed in various cancers, making them promising targets for drug intervention. Researchers have leveraged the reactivity of the chloromethyl group to develop bispecific inhibitors that can simultaneously bind to two different targets, enhancing therapeutic efficacy. Such strategies have shown promise in preclinical studies, particularly for treating resistant forms of cancer.

The bromo substituent on the pyridine ring also contributes to the compound's utility as a scaffold for further derivatization. Bromine is known to be a good leaving group in nucleophilic substitution reactions, allowing for the introduction of diverse functional groups at specific positions on the ring. This flexibility has been exploited in designing libraries of compounds for high-throughput screening (HTS) to identify novel bioactive molecules.

In addition to its role in oncology research, 3-Bromo-5-(chloromethyl)-4-methylpyridine has shown potential in other therapeutic areas. For instance, it has been used as an intermediate in synthesizing antiviral agents targeting RNA-dependent RNA polymerases (RdRp) found in viruses like influenza and HIV. The chloromethyl group can be readily converted into other functional moieties such as alcohols or amines, which are crucial for optimizing pharmacokinetic properties and improving drug-like characteristics.

The compound's significance extends beyond pharmaceutical applications into agrochemical research. Pyridine derivatives are commonly used as key components in herbicides and pesticides due to their ability to interfere with essential enzymatic pathways in plants and pests. The bromo and chloromethyl groups enhance the reactivity of these compounds, allowing for more effective binding to biological targets.

The synthesis of 3-Bromo-5-(chloromethyl)-4-methylpyridine typically involves multi-step organic reactions starting from commercially available pyridine precursors. Key steps often include halogenation reactions to introduce the bromo group, followed by nucleophilic substitution or condensation reactions to incorporate the chloromethyl moiety. Advanced synthetic techniques such as palladium-catalyzed cross-coupling reactions have also been employed to achieve higher regioselectivity and yield.

The purity and quality of 3-Bromo-5-(chloromethyl)-4-methylpyridine are critical factors that influence its applicability in research and development. High-purity compounds ensure reliable results in biological assays and minimize side reactions during synthesis. Analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and high-performance liquid chromatography (HPLC) are routinely employed to confirm structural integrity and assess purity.

In conclusion, 3-Bromo-5-(chloromethyl)-4-methylpyridine is a valuable intermediate with broad applications in pharmaceuticals and agrochemicals. Its unique structural features make it a versatile building block for designing bioactive molecules targeting various diseases. Ongoing research continues to explore new synthetic methodologies and applications, reinforcing its importance in modern chemical biology.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)